Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Voyager Therapeutics (VYGR) Other Working Capital Changes: 2015-2025

Historic Other Working Capital Changes for Voyager Therapeutics (VYGR) over the last 11 years, with Sep 2025 value amounting to -$11.1 million.

  • Voyager Therapeutics' Other Working Capital Changes fell 112.69% to -$11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.7 million, marking a year-over-year increase of 51.94%. This contributed to the annual value of -$44.8 million for FY2024, which is 576.33% down from last year.
  • Voyager Therapeutics' Other Working Capital Changes amounted to -$11.1 million in Q3 2025, which was down 305.53% from -$2.7 million recorded in Q2 2025.
  • Voyager Therapeutics' Other Working Capital Changes' 5-year high stood at $53.3 million during Q1 2022, with a 5-year trough of -$30.9 million in Q3 2022.
  • For the 3-year period, Voyager Therapeutics' Other Working Capital Changes averaged around -$4.9 million, with its median value being -$4.5 million (2025).
  • Within the past 5 years, the most significant YoY rise in Voyager Therapeutics' Other Working Capital Changes was 1,518.80% (2022), while the steepest drop was 5,521.49% (2022).
  • Over the past 5 years, Voyager Therapeutics' Other Working Capital Changes (Quarterly) stood at $1.2 million in 2021, then skyrocketed by 48.89% to $1.8 million in 2022, then crashed by 479.07% to -$6.8 million in 2023, then surged by 35.96% to -$4.4 million in 2024, then crashed by 112.69% to -$11.1 million in 2025.
  • Its last three reported values are -$11.1 million in Q3 2025, -$2.7 million for Q2 2025, and -$4.5 million during Q1 2025.